Abstract
Background
The evidence for the associations between early-life adiposity and female cancer risks is mixed. Little is known about the exact shape of the relationships and whether the associations are independent of adult adiposity.
Methods
We conducted dose–response meta-analyses of prospective studies to summarise the relationships of early-life body mass index (BMI) with breast, endometrial, and ovarian cancer risks. Pubmed and Embase were searched through June 2020 to identify relevant studies. Using random-effects models, the summary relative risks (RRs) and 95% confidence intervals (CIs) were estimated per 5-kg/m2 increase in BMI at ages ≤ 25 years. A nonlinear dose–response meta-analysis was conducted using restricted cubic spline analysis.
Results
After screening 33,948 publications, 37 prospective studies were included in this analysis. The summary RRs associated with every 5-kg/m2 increase in early-life BMI were 0.84 (95% CI = 0.81–0.87) for breast, 1.40 (95% CI = 1.25–1.57) for endometrial, and 1.15 (95% CI = 1.07–1.23) for ovarian cancers. For breast cancer, the association remained statistically significant after adjustment for adult BMI (RR = 0.80, 95% CI = 0.73–0.87). For premenopausal breast, endometrial, and ovarian cancers, the dose–response curves suggested evidence of nonlinearity.
Conclusions
With early-life adiposity, our data support an inverse association with breast cancer and positive associations with ovarian and endometrial cancer risks.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Available upon request.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Peeters PHM, Verbeek ALM, Krol A, Matthyssen MMM, Dewaard F. Age at menarche and breast-cancer risk in nulliparous women. Breast Cancer Res Treat. 1995;33:55–61.
Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk-factors for breast-cancer - associations and interactions in an international case-control study. Int J Cancer. 1990;46:796–800.
McPherson CP, Sellers TA, Potter JD, Bostick RM, Folsom AR. Reproductive factors and risk of endometrial cancer—the Iowa women’s health study. Am J Epidemiol. 1996;143:1195–202.
Fujita M, Tase T, Kakugawa Y, Hoshi S, Nishino Y, Nagase S, et al. Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in japanese: a case-control study. Tohoku J Exp Med. 2008;216:297–307.
Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW. The independent associations of parity, age at 1st full term pregnancy, and duration of breastfeeding with the risk of breast-cancer. J Clin Epidemiol. 1989;42:963–73.
Titus-Ernstoff L, Perez K, Cramer DW, Harlow BL, Baron JA, Greenberg ER. Menstrual and reproductive factors in relation to ovarian cancer risk. Br. J Cancer. 2001;84:714–21.
Salagame U, Banks E, O’Connell DL, Egger S, Canfell K. Menopausal hormone therapy use and breast cancer risk by receptor subtypes: results from the new south wales cancer lifestyle and evaluation of risk (CLEAR) study. PLoS ONE. 2018;13:e0205034.
Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, et al. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128:144–56.
Doherty, JA, Cushing-Haugen, KL, Saltzman, BS, Voigt, LF, Hill, DA, Beresford, SA, et al. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Am J Obstet Gynecol. 2007;197: 139-e1.
Lacey JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288:334–41.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.
Aune D, Rosenblatt DAN, Chan DSM, Vingeliene S, Abar L, Vieira AR, et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies. Ann Oncol. 2015;26:1635–48.
Aune D, Rosenblatt DAN, Chan DSM, Abar L, Vingeliene S, Vieira AR, et al. Anthropometric factors and ovarian cancer risk: A systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer. 2015;136:1888–98.
Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. N Engl J Med. 2004;351:1619–26.
Keinan-Boker L, Levine H, Derazne E, Molina-Hazan V, Kark JD. Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women. Breast Cancer Res Treat. 2016;158:157–67.
Fagherazzi G, Guillas G, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S. Body shape throughout life and the risk for breast cancer at adulthood in the French E3N cohort. Eur J Cancer Prev. 2013;22:29–37.
Kawai M, Minami Y, Kuriyama S, Kakizaki M, Kakugawa Y, Nishino Y, et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Brit J Cancer. 2010;103:1443–7.
Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomark Prev.2007;16:1795–802.
Weiderpass E, Braaten T, Magnusson C, Kumle M, Vainio H, Lund E, et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomark Prev. 2004;13:1121–7.
Sellers TA, Davis J, Cerhan JR, Vierkant RA, Olson JE, Pankratz VS, et al. Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol. 2002;155:225–33.
Hilakivi-Clarke L, Forsen T, Eriksson JG, Luoto R, Tuomilehto J, Osmond C, et al. Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer. 2001;85:1680–4.
Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol. 2010;171:1183–94.
Stevens VL, Jacobs EJ, Patel AV, Sun JZ, Gapstur SM, McCullough ML. Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones. Cancer Cause Control. 2014;25:321–8.
Dougan MM, Hankinson SE, De Vivo I, Tworoger SS, Glynn RJ, Michels KB. Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer. 2015;137:625–37.
Yang TYO, Cairns BJ, Allen N, Sweetland S, Reeves GK, Beral V, et al. Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Brit J Cancer. 2012;107:169–75.
Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW. Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort. Int J cancer. 2010;126:490–9.
Sponholtz TR, Palmer JR, Rosenberg L, Hatch EE, Adams-Campbell LL, Wise LA. Body size, metabolic factors, and risk of endometrial cancer in black women. Am J Epidemiol. 2016;183:259–68.
Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, et al. Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol. 2003;157:113–20.
Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst. 2003;95:1244–8.
Aarestrup J, Trabert B, Ulrich LG, Wentzensen N, Sorensen TIA, Baker JL. Childhood overweight, tallness, and growth increase risks of ovarian cancer. Cancer Epidemiol Biomarkers Prev.2019;28:183–8.
Burton A, Martin R, Galobardes B, Smith GD, Jeffreys M. Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Cause Control. 2010;21:2069–77.
Baer HJ, Hankinson SE, Tworoger SS. Body size in early life and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Brit J Cancer. 2008;99:1916–22.
Schouten LJ, Goldbohm RA, van den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Am J Epidemiol. 2003;157:424–33.
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer. 2013;20:251–62.
Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, et al. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status-the Japan public health center-based prospective study. Int J Cancer. 2011;129:1214–24.
Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, et al. Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomark Prev. 2008;17:902–12.
Premenopausal Breast Cancer Collaborative G, Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4:e181771.
Chan DSM, Abar L, Cariolou M, Nanu N, Greenwood DC, Bandera EV, et al. World Cancer Research Fund International: continuous update project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer Causes Control. 2019;30:1183–200.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.
De Stavola B, dos Santos Silva I, McCormack V, Hardy R, Kuh D, Wadsworth M. Childhood growth and breast cancer. Am J Epidemiol. 2004;159:671–82.
Torio CM, Klassen AC, Curriero FC, Caballero B, Helzlsouer K. The modifying effect of social class on the relationship between body mass index and breast cancer incidence. Am J Public Health. 2010;100:146–51.
White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR. Body size and breast cancer risk: the MULTIETHNIC Cohort. Int J Cancer. 2012;131:E705–16.
Krishnan K, Bassett JK, MacInnis RJ, English DR, Hopper JL, McLean C., et al.Associations between weight in early adulthood, change in weight, and breast cancer risk in postmenopausal women.Cancer Epidemiol Biomarkers Prev. 2013;22:1409–16.
Andersen ZJ, Baker JL, Bihrmann K, Vejborg I, Sørensen TI, Lynge E. Birth weight, childhood body mass index, and height in relation to mammographic density and breast cancer: a register-based cohort study. Breast Cancer Res. 2014;16:R4.
Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, et al. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Cause Control. 2010;21:1407–16.
Stunkard AJ. Use of the Danish adoption register for the study of obesity and thinness. Res Publ Assoc Res Nerv Ment Dis. 1983;60:115–20.
Sørensen T, Stunkard A, Teasdale T, Higgins M. The accuracy of reports of weight: children’s recall of their parents’ weights 15 years earlier. Int J Obes. 1983;7:115–22.
Must A, Willett WC, Dietz WH. Remote recall of childhood height, weight, and body build by elderly subjects. Am J Epidemiol. 1993;138:56–64.
Wells, GA, Shea, B, O’Connell, D, Peterson, J, Welch, V, Losos, M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Accessed 15, July, 2021.
Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–9.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177–88.
Harre FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80:1198–202.
Orsini N, Greenland S. A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. Stata J. 2011;11:1–29.
Organization, WH. Obesity: preventing and managing the global epidemic. (World Health Organization, 2000).
White IR. Multivariate random-effects meta-analysis. Stata J. 2009;9:40–56.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Stat Med. 2002;21:1539–58.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods. 2006;11:193–206.
Horn-Ross, PL, Canchola, AJ, Bernstein, L, Neuhausen, SL, Nelson, DO & Reynolds, P. Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort. Breast Cancer Res. 2016;18:132.
Luo J, Chen X, Manson JE, Shadyab AH, Wactawski‐Wende J, Vitolins M, et al. Birth weight, weight over the adult life course and risk of breast cancer. Int J Cancer. 2020;147:65–75.
van den Brandt PA, Dirx MJ, Ronckers CM, van den Hoogen P, Goldbohm RA. Height, weight, weight change, and postmenopausal breast cancer risk: the Netherlands Cohort Study. Cancer Cause Control. 1997;8:39–47.
Cerhan JR, Grabrick DM, Vierkant RA, Janney CA, Vachon CM, Olson JE, et al. Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA). Cancer Cause Control. 2004;15:1–9.
Renehan AG, Pegington M, Harvie MN, Sperrin M, Astley SM, Brentnall AR, et al. Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom). Br J Cancer. 2020;122:1552–61.
Gapstur SM, Potter JD, Sellers TA, Kushi LH, Folsom AR. Alcohol consumption and postmenopausal endometrial cancer: results from the Iowa Women’s Health Study. Cancer Cause Control. 1993;4:323–9.
Schouten LJ, Goldbohm RA. & Van Den Brandt, P. A. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst. 2004;96:1635–1638.
Chang S-C, Lacey JV, Brinton LA, Hartge P, Adams K, Mouw T, et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol, Biomark Prev. 2007;16:723–30.
Han X, Stevens J, Truesdale KP, Bradshaw PT, Kucharska‐Newton A, Prizment AE, et al. Body mass index at early adulthood, subsequent weight change and cancer incidence and mortality. Int J Cancer. 2014;135:2900–9.
Anderson JP, Ross JA, Folsom AR. Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Women’s Health Study. Cancer. 2004;100:1515–21.
Leitzmann MF, Koebnick C, Danforth KN, Brinton LA, Moore SC, Hollenbeck AR, et al. Body mass index and risk of ovarian cancer. Cancer: Interdisciplinary. Int J Am Cancer Soc. 2009;115:812–22.
Huang T, Tworoger S, Willett W, Stampfer M, Rosner B. Associations of early life and adulthood adiposity with risk of epithelial ovarian cancer. Ann Oncol. 2019;30:303–9.
Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Preventive Med. 1993;22:167–77.
Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911–9.
Haffner SM, Miettinen H. Karhapää, P., Mykkänen, L. & Laakso, M. Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab. 1997;82:1807–9.
Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23:83–9.
Ginsburg OM, Martin LJ, Boyd NF. Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer. 2008;99:1369–74.
Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature. 1983;303:767–70.
Poole EM, Tworoger SS, Hankinson SE, Schernhammer ES, Pollak MN, Baer HJ. Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3. Am J Epidemiol. 2011;174:642–51.
Hormones TE, Group BCC. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol. 2010;11:530–42.
Oh H, Pfeiffer RM, Falk RT, Horne HN, Xiang J, Pollak M, et al. Serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank. Int J Cancer. 2018;143:496–507.
Bertrand KA, Baer HJ, Orav EJ, Klifa C, Shepherd JA, Van Horn L, et al. Body fatness during childhood and adolescence and breast density in young women: a prospective analysis. Breast Cancer Res. 2015;17:95.
Oh H, Rice MS, Warner ET, Bertrand KA, Fowler EE, Eliassen AH., et al. Early-life and adult anthropometrics in relation to mammographic image intensity variation in the Nurses’ Health Studies. Cancer Epidemiol Biomarkers Prev.2020;29:343–51.
Oh, H, Yaghjyan, L, Austin-Datta, RJ, Heng, YJ, Baker, GM, Sirinukunwattana, K, et al. Early-life and adult adiposity, adult height, and benign breast tissue composition. Cancer Epidemiol Biomarkers Prev. 2021;30:608–615.
Oh H, Eliassen AH, Beck AH, Rosner B, Schnitt SJ, Collins LC, et al. Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue. NPJ Breast Cancer. 2017;3:1–8.
Wang, J, Peng, C, Askew, C, Heng, YJ, Baker, GM, Rubadue, CA, et al. Early-life body adiposity and the breast tumor transcriptome. J Natl Cancer Inst. 2020; https://doi.org/10.1093/jnci/djaa169.
Rice MS, Bertrand KA, VanderWeele TJ, Rosner BA, Liao X, Adami H-O, et al. Mammographic density and breast cancer risk: a mediation analysis. Breast Cancer Res. 2016;18:1–13.
Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O’Brien KM, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4:e181771–e181771.
Acknowledgements
Not applicable.
Funding
HO was supported by the National Research Foundation of Korea (NRF) grants (2019R1G1A1004227, 2019S1A3A2099973) and Korea University grant L1906811. NK was supported by the National Research Foundation of Korea (NRF) grants (2018R1C1B6008822, 2018R1A4A1022589). The funders were not involved in the study design or data analysis and the views expressed in this publication are those of the authors.
Author information
Authors and Affiliations
Contributions
DB conducted literature search, performed data extraction, and wrote the paper. SH performed statistical analyses and wrote the paper. SR, YN, HJ and YC conducted literature search and performed data extraction. HO and NK designed the research and made substantial contributions to interpretation of data, and critical revision and editing of the manuscript. All authors revised the manuscript for important intellectual content and gave final approval of the version to be published.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
Not applicable.
Consent to publish
Not applicable.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Byun, D., Hong, S., Ryu, S. et al. Early-life body mass index and risks of breast, endometrial, and ovarian cancers: a dose–response meta-analysis of prospective studies. Br J Cancer 126, 664–672 (2022). https://doi.org/10.1038/s41416-021-01625-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-021-01625-1
This article is cited by
-
Glucose metabolic reprogramming and its therapeutic potential in obesity-associated endometrial cancer
Journal of Translational Medicine (2023)
-
Aerobic, muscle-strengthening, and flexibility physical activity and risks of all-cause and cause-specific mortality: a population-based prospective cohort of Korean adults
BMC Public Health (2023)
-
Dose response relationship between breast cancer and somatotypes during childhood: a systematic review and meta-analysis
British Journal of Cancer (2023)
-
The Role of Cow’s Milk Consumption in Breast Cancer Initiation and Progression
Current Nutrition Reports (2023)
-
The timing of adiposity and changes in the life course on the risk of cancer
Cancer and Metastasis Reviews (2022)